SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased trading activity and community buzz ahead of the anticipated Goliath mainnet launch. Investors are debating its long-term potential as a payment infrastructure asset, with many monitoring for signs of sustained upward momentum while others express frustration over historical volatility and price suppression.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: PepsiCo Foods North America (PFNA), PepsiCo Beverages North America (PBNA), International Beverages Franchise (IB Franchise), Europe, Middle East and Africa (EMEA), Latin America Foods (LatAm Foods), and Asia Pacific Foods. The PFNA segment refers to the food businesses in the United States and Canada. The PBNA segment includes beverage businesses in the United States and Canada. The IB Franchise segment involves the international franchise beverage businesses, as well as the SodaStream business. The EMEA segment pertains to food businesses and beverage businesses with company-owned bottlers in Europe, the Middle East, and Africa. The LatAm Foods segment consists of food businesses in Latin America. The Asia Pacific Foods segment is associated in food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is currently facing heightened scrutiny and market pressure following the disclosure of a $4 billion stake by Elliott Management, which has prompted negotiations over potential operational overhauls and cost-cutting measures. Community sentiment remains mixed, as investors weigh the company's attempts to lower food prices and streamline its U.S. product portfolio against ongoing concerns regarding soft volume growth and the broader sustainability of its current dividend payout strategy.

Netskope, Inc. engages in the provision of cloud based security solutions. It offers business developing analytics for visibility, policy enforcement and other cloud solutions. Its products include Netskope one SASE, Netskope one SSE, cloud access security broker, next generation secure web gateway, private access, cloud firewall, SD-WAN and skopeAI. The company was founded by Sanjay Beri, Lebin Cheng, Ravishankar Ithal, and Krishna Narayanaswamy in October 2012 and is headquartered in Santa Clara, CA.

Netskope Inc. - Ordinary Shares - Class A

Netskope is drawing significant interest following a volatile post-IPO period, with the community closely tracking institutional accumulation despite broader sector weakness. Investors are focused on the company's long-term potential in the cloud security and AI sectors, balancing concerns over upcoming lock-up expirations against substantial institutional inflows and bullish analyst initiations.

Cracker Barrel Old Country Store, Inc. engages in the operation and development of restaurant and retail outlets. The format of its stores consists of a trademarked rustic old country-store design that offers restaurant menu featuring home-style country food. The company was founded by Dan W. Evins on September 19, 1969 and is headquartered in Lebanon, TN.

Cracker Barrel Old Country Store Inc

Cracker Barrel is facing significant downward pressure as investors grow increasingly frustrated with the current leadership team, menu changes, and ongoing rebranding challenges. While the community is actively debating the company's turnaround prospectsciting its extensive real estate portfolio as a potential floormany are calling for a complete overhaul of management to resolve the persistent decline in performance.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending due to strong market anticipation surrounding its upcoming earnings report and the strategic acquisition of Valaris, which positions the company as a dominant offshore drilling powerhouse with improved pricing power. Investors are closely monitoring the company's efforts to reduce debt and expand its contract backlog, while community discussions highlight excitement over the long-term potential of the offshore sector amidst rising geopolitical energy security concerns.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens is trending as investors react to institutional integration news and the expansion of real-world asset tokenization, though the community remains polarized between long-term optimism and frustrations over ongoing price volatility. Discussions are heavily focused on the project's utility and regulatory potential, with many traders analyzing technical patterns and comparing the coin's performance to other major assets.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as investors digest news of its strategic acquisition of select Rite Aid assets and a positive price target hike from Goldman Sachs. The community remains focused on the company's turnaround progress under CEO David Joyner, balancing enthusiasm for its integrated healthcare model against lingering concerns over government reimbursement policies and regulatory oversight.

iShares Inc. - iShares MSCI Israel ETF

iShares MSCI Israel ETF

The iShares MSCI Israel ETF is experiencing high volatility as investors weigh the potential for a peace dividend against ongoing geopolitical instability. Market participants are actively debating the long-term viability of the Israeli economy, with some pointing to resilient tech sector growth and recent all-time highs as evidence of strength, while others advocate for divestment due to the risks of prolonged conflict and military-related regional tensions.

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals is experiencing heightened market attention and volatility driven by investor speculation over a potential buyout by major pharmaceutical players as the company continues to execute on its commercial launch and clinical pipeline. Community sentiment is deeply divided between long-term holders optimistic about the transformative potential of setmelanotide in rare obesity disorders and short-term traders reacting to insider selling activity and the company's path to profitability.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The DJIA is trending as investors closely monitor potential shifts in Federal Reserve policy, with significant attention on upcoming leadership transitions and persistent inflation concerns. The community is actively debating the broader economic landscape, weighing the impact of ongoing geopolitical tensions and corporate layoffs against continued market resilience.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Radcliffe Capital Management L.P. Takes $1.23 Million Position in Pacira BioSciences, Inc. $PCRX

Radcliffe Capital Management L.P. bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F...

DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.

DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc. DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences...

Pacira BioSciences (NASDAQ:PCRX) Downgraded to "Strong Sell" Rating by Zacks Research

Zacks Research cut Pacira BioSciences from a "hold" rating to a "strong sell" rating in a research report on Monday...

Pacira BioSciences (NASDAQ:PCRX) Stock Price Up 4.6% - What's Next?

Pacira BioSciences (NASDAQ:PCRX) Shares Up 4.6% - What's Next...

Wall Street Zen Downgrades Pacira BioSciences (NASDAQ:PCRX) to Buy

Wall Street Zen cut Pacira BioSciences from a "strong-buy" rating to a "buy" rating in a report on Saturday...

Pacira BioSciences (NASDAQ:PCRX) Shares Gap Down - What's Next?

Pacira BioSciences (NASDAQ:PCRX) Shares Gap Down - Here's What Happened...

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

PCRX misses Q4 earnings and revenue estimates as expenses surge and shares slide, despite Exparel growth and a new 2026 outlook.

Pacira BioSciences Q4 Earnings Call Highlights

Pacira BioSciences (NASDAQ:PCRX) executives used the company's fourth-quarter and full-year 2025 earnings call to highlight what CEO Frank Lee described as a transformative year, pointing to renewed...

Pacira BioSciences (NASDAQ:PCRX) Releases Earnings Results, Misses Expectations By $0.28 EPS

Pacira BioSciences (NASDAQ:PCRX - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.57 earnings per share (EPS) for the quarter, missing the consensus...

Compared to Estimates, Pacira (PCRX) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Pacira (PCRX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Current Price	$23.26
Prev Close	$23.53
Open	$23.30
Dividend Yield	0.00%
50-Day Moving Average	$22.18
Beta	0.39
Avg. Volume	836,694.97
PE Ratio	148.06

52-Week High	$27.64
52-Week Low	$18.80
Market Capitalization	$941.79M
EPS (Annual)	$0.1562
Price to Book	1.38
Revenue Per Employee	$876,249.70

PCRX
Pacira BioSciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PCRX News

PCRXPacira BioSciences Inc